JP Morgan Chase
ABMD

JP Morgan Chase’s Abiomed Inc ABMD Stock Holding History

JP Morgan Chase’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-39,900
Closed -$12.9M – 6476
2020
Q4 		$12.9M Buy
+39,900
New +$11M ﹤0.01% 1989
2020
Q1 		– Sell
-37,100
Closed -$6.33M – 5860
2019
Q4 		$6.33M Buy
+37,100
New +$6.88M ﹤0.01% 2500
2019
Q2 		– Sell
-40,000
Closed -$11.4M – 6101
2019
Q1 		$11.4M Buy
40,000
+37,500
+1,500% +$12.5M ﹤0.01% 1935
2018
Q4 		$813K Buy
+2,500
New +$868K ﹤0.01% 3870

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's ABMD Position: Q4 2022 in Review

JP Morgan Chase sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 218,051 shares — an estimated $53.6M sold.

JP Morgan Chase first reported a position in ABMD in Q2 2013 and held it in 32 quarters. The position peaked at $187M in Q2 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • JP Morgan Chase reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 218,051 Abiomed Inc shares in Q4 2022, an estimated $53.6M.
  • JP Morgan Chase first reported a position in Abiomed Inc in Q2 2013 and held it in 32 quarters.
  • JP Morgan Chase's Abiomed Inc position peaked at $187M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.